EUVIMEDEUVIMED entdecken
Crossref

Discovery of 5‐alkyl‐2‐pyrazol‐oxazolidin‐4‐one derivatives as novel hepatitis B virus capsid assembly modulators

Mengying Guan, Yuan Wang, Yunwen Wang, Na Chen, Shu Shi, Rong Sheng

Archiv der Pharmazie · 2023

DOI: 10.1002/ardp.202200592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2023. Verfasst von Mengying Guan und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Hepatitis B virus, Capsid. Die Arbeit nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The “magic methyl effect” strategy was used to design a series of 5‐alkyl‐2‐pyrazol‐oxazolidin‐4‐one derivatives as novel hepatitis B virus (HBV) capsid assembly modulators. Most of these compounds exhibited potent HBV inhibitory activities with low cytotoxicities in HepG2.2.15 cells. The most promising compounds 9d and 10b had single‐digit nanomolar IC 50 values with a high selectivity index. Compared with the lead compound (3.0%), they caused 15% and 18% decreases in HBe antigen secretion at 1.0 μM, respectively. In addition, compounds 9d and 10b possessed good pharmacokinetic profiles with oral bioavailability values of 56.1% and 48.9%, respectively. These results indicated that the two compounds were potential therapeutic agents for HBV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusCapsidVirus AssemblyAntiviral AgentsStructure-Activity RelationshipCapsid ProteinsVirus Replication

Stichwörter der Autor:innen

HBVcapsid assembly modulatorsmagic methyl effectpyrazol-oxazolidin-4-onesstructure optimization

Substanzen

Antiviral AgentsCapsid Proteins

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
  • Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Guan, M., Wang, Y., Wang, Y., Chen, N., Shi, S., & Sheng, R. (2023). Discovery of 5‐alkyl‐2‐pyrazol‐oxazolidin‐4‐one derivatives as novel hepatitis B virus capsid assembly modulators. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202200592

Vancouver

Guan M, Wang Y, Wang Y, Chen N, Shi S, Sheng R. Discovery of 5‐alkyl‐2‐pyrazol‐oxazolidin‐4‐one derivatives as novel hepatitis B virus capsid assembly modulators. Archiv der Pharmazie. 2023. doi:10.1002/ardp.202200592

BibTeX
@article{Guan2023,
  author = {Guan, Mengying and Wang, Yuan and Wang, Yunwen and Chen, Na and Shi, Shu and Sheng, Rong},
  title = {Discovery of 5‐alkyl‐2‐pyrazol‐oxazolidin‐4‐one derivatives as novel hepatitis B virus capsid assembly modulators},
  journal = {Archiv der Pharmazie},
  year = {2023},
  doi = {10.1002/ardp.202200592}
}
Kostenlos starten →